Grail (GRAL) 股价跌破 70 美元：现在是买入、卖出还是持有的时机？
· finance.yahoo.com
这家血液癌症检测开发商的前景依然光明。
Grail (NASDAQ: GRAL), which was spun off from Illumina (NASDAQ: ILMN) in 2024, reached a record high of $116.06 on Jan. 22. But today, the cancer test developer...
· finance.yahoo.com
这家血液癌症检测开发商的前景依然光明。
Grail (NASDAQ: GRAL), which was spun off from Illumina (NASDAQ: ILMN) in 2024, reached a record high of $116.06 on Jan. 22. But today, the cancer test developer...
More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI